Teva Pharmaceutical Industries (TEVA) Other Working Capital Changes (2017 - 2025)
Historic Other Working Capital Changes for Teva Pharmaceutical Industries (TEVA) over the last 17 years, with Q4 2025 value amounting to -$1.5 billion.
- Teva Pharmaceutical Industries' Other Working Capital Changes fell 399189.19% to -$1.5 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $83.0 million, marking a year-over-year decrease of 8870.75%. This contributed to the annual value of $81.0 million for FY2025, which is 8553.57% down from last year.
- Per Teva Pharmaceutical Industries' latest filing, its Other Working Capital Changes stood at -$1.5 billion for Q4 2025, which was down 399189.19% from $561.0 million recorded in Q3 2025.
- Teva Pharmaceutical Industries' 5-year Other Working Capital Changes high stood at $1.1 billion for Q1 2021, and its period low was -$4.2 billion during Q4 2021.
- In the last 5 years, Teva Pharmaceutical Industries' Other Working Capital Changes had a median value of $82.5 million in 2021 and averaged -$137.3 million.
- Per our database at Business Quant, Teva Pharmaceutical Industries' Other Working Capital Changes surged by 37924.53% in 2024 and then crashed by 399189.19% in 2025.
- Quarter analysis of 5 years shows Teva Pharmaceutical Industries' Other Working Capital Changes stood at -$4.2 billion in 2021, then surged by 91.62% to -$348.0 million in 2022, then grew by 12.93% to -$303.0 million in 2023, then soared by 87.79% to -$37.0 million in 2024, then tumbled by 3991.89% to -$1.5 billion in 2025.
- Its Other Working Capital Changes stands at -$1.5 billion for Q4 2025, versus $561.0 million for Q3 2025 and $336.0 million for Q2 2025.